Working… Menu
Trial record 2 of 2 for:    STARTRK-2

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. (RNASARC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03375437
Recruitment Status : Recruiting
First Posted : December 18, 2017
Last Update Posted : February 11, 2021
Hoffmann-La Roche
Information provided by (Responsible Party):
Centre Leon Berard

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 15, 2022
Estimated Study Completion Date : January 15, 2023
Publications of Results:
Other Publications: